Salmonics develops and manufactures plasma, serum, and purified proteins derived from fish blood, offering researchers a robust non-mammalian alternative to traditional biological reagents. Our materials deliver consistent performance across immunoassays (e.g., ELISA, Western blot), cell culture, and ECM applications.
By eliminating mammalian components, Salmonics products reduce pathogen risk and experimental variability while ensuring reliable lot-to-lot consistency and secure supply. We support both research and commercial development through ready-to-use reagents as well as bulk raw material inputs for manufacturers, including purified proteins (e.g., fibrinogen, fibronectin) and custom formulations designed for integration into diagnostic kits, assays, and finished products.
Our goal is to provide high-performing, reproducible solutions that integrate seamlessly into existing workflows—enabling more robust results and advancing innovation in areas such as wound healing and pain management.